TG Therapeutics Inc.

NASDAQ: TGTX · Real-Time Price · USD
28.05
0.28 (1.01%)
At close: Aug 15, 2025, 3:59 PM
28.15
0.34%
After-hours: Aug 15, 2025, 05:55 PM EDT

TG Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
23.38M 12.67M -198.34M -348.1M
Depreciation & Amortization
280K 423K 515K 494K
Stock-Based Compensation
42.54M 37.93M 19.18M 61.27M
Other Working Capital
12.81M -84.66M 7.97M -10.83M
Other Non-Cash Items
2.58M 2.22M 4.11M 2.4M
Deferred Income Tax
n/a n/a n/a 517K
Change in Working Capital
-109.3M -84.66M -1.65M -12.22M
Operating Cash Flow
-40.52M -31.41M -176.17M -295.63M
Capital Expenditures
-45K n/a -14K -401K
Cash Acquisitions
n/a n/a 20M -69K
Purchase of Investments
-311.89M -146.88M -107.27M -55.53M
Sales Maturities Of Investments
310.9M 96.23M 87.28M 55.6M
Other Investing Acitivies
n/a n/a -20M 69K
Investing Cash Flow
-1.04M -50.65M -20.01M -332K
Debt Repayment
137.26M 25M -975K 40M
Common Stock Repurchased
-8.76M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
25K 1.41M n/a -800K
Financial Cash Flow
128.53M 72.7M -391K 41.42M
Net Cash Flow
86.97M -9.36M -196.57M -254.55M
Free Cash Flow
-40.56M -31.41M -176.18M -296.04M